Roman G. Rubio serves as Executive at Avalanche Biotechnologies, Inc., where they oversee executive responsibilities. Since joining the company, Roman G. Rubio has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 12, 2016 involved receiving (via award) 50,000 shares valued at $0.
Roman G. Rubio currently holds 165,650 shares of Avalanche Biotechnologies, Inc. (AAVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roman G. Rubio has been a net neutral trader of AAVL stock. They have purchased $0 and sold $0 worth of shares.
Roman G. Rubio's most recent insider trade was on Feb 12, 2016, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 21, 2015 | AAVL | $0 | Award | 7,000 | $N/A | Discretionary |